Literature DB >> 22051625

[Breast implant infection by Mycobacterium fortuitum in a patient with systemic lupus erythematosus].

Diego Lizaso1, Mercedes García, Ana Aguirre, Amadeo Esposto.   

Abstract

In recent decades there has been an increase in the number of breast implants for reconstruction and cosmetic purposes. Infection is a severe complication mostly caused by Staphylococcus aureus or coagulase-negative staphylococci. Mycobacteria are an infrequent cause of infection in this type of surgery. We describe a case of Mycobacterium fortuitum infection in a patient with lupus, subjected to a prosthetic replacement. These patients are more prone to unusual opportunistic infections. Treatment always requires both removal of prosthetic material and antibiotic therapy.

Entities:  

Mesh:

Year:  2011        PMID: 22051625     DOI: /S0716-10182011000600013

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  4 in total

1.  Application time for postoperative wound dressing following breast augmentation with implants: study protocol for a randomized controlled trial.

Authors:  Denise de Almeida Mendes; Daniela Francescato Veiga; Joel Veiga-Filho; Fernando Elias Martins Fonseca; Luiz Francisley de Paiva; Neil Ferreira Novo; Ana Beatriz Alkmin Teixeira Loyola; Lydia Masako Ferreira
Journal:  Trials       Date:  2015-01-27       Impact factor: 2.279

2.  How I Can Suspect of Mycobacteria Infection in Breast Implant Surgery?

Authors:  Guillermo Ramos-Gallardo
Journal:  World J Plast Surg       Date:  2016-09

Review 3.  Nontuberculous mycobacterial infections: a potential complication of cosmetic procedures.

Authors:  Tiara Hypolite; Jane M Grant-Kels; Lisa M Chirch
Journal:  Int J Womens Dermatol       Date:  2015-02-24

4.  Mycobacterial infection of breast prosthesis--a conservative treatment: a case report.

Authors:  David Atallah; Nadine El Kassis; George Araj; Marwan Nasr; Roy Nasnas; Nicolas Veziris; Dolla Sarkis
Journal:  BMC Infect Dis       Date:  2014-05-05       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.